SAHPRA approved masks will be distributed by Uvukile Medical & Surgical Supplies (PTY) LTD, a South African distribution partner.
South Africa will be the first country to join The Viracide™ Deactivation Nation global movement
NEW YORK--(BUSINESS WIRE)--(BUSINESS WIRE)--Today, Vitiprints LLC announced the launch of Viracide™ Masks in Africa through a distribution partnership with Uvukile Medical and Surgical Supplies (PTY) LTD.
SAHPRA-approved medical-grade Viracide™ masks have anti-viral and anti-bacterial coatings, providing additional tools to fight COVID-19, and will initially be marketed in neighboring countries such as South Africa and Lesotho and Swaziland. There are more than 172,000 COVID-19-related deaths in Africa, and the African continent now accounts for more than 4% of the 5 million COVID-19-related deaths recorded globally. Viracide™ masks will provide an accessible and affordable solution to ensure people's safety.
South Africa is the first country to join The Viracide™ Deactivation Nation global movement-calling on countries around the world to take action to unite and stop COVID-19 by encouraging citizens to wear Viracide™ masks.
What's different about Viracide™ mask
These masks protect users with a proprietary antiviral/antibacterial coating that can inactivate 99.97% of SARS-CoV-2 and 99% of human coronavirus (229E) within one minute of contact with the surface of the mask. The disruptive technology used in Viracide™ masks will help save lives by preventing the spread of COVID-19 and its variants. Wearing a mask is the most effective public health measure against COVID-19, which can reduce the incidence rate by 53%. This is the first global study of this kind completed by the highly regarded medical journal BMJ. Viracide™ masks can reduce the incidence to a greater extent, provide the wearer with masks and enhanced antiviral function.
As the director of Uvukile Medical and Surgical Supplies (PTY) Ltd. said: “South Africa and its neighbouring countries now need a real anti-viral mask that can be sold at an affordable price.” “We believe that the use of Viracide™ masks will prevent COVID- 19 The spread in Africa has a direct impact. We are working with SAHPRA and other government and humanitarian agencies across the African continent to control COVID and save lives." UMS sales teams are strategically deployed in South Africa and several African countries (including But not limited to the national sales footprint of Namibia, Botswana and Zimbabwe. For more than 20 years, UMS' leadership position has been trusted and widely known in the medical field and other key industries. With a trusted global partner network, UMS Africa will lead the future expansion of Viracide™ masks and the ever-expanding Viracide™ product line.
What is the potential impact of containing COVID-19 in Africa?
A data modeling exercise conducted by Dr. Marya Ghazipura, MS and epidemiologist and biostatistician of New York University Lange Health’s New York City COVID-19 Scientific Advisory Committee concluded that territories in Africa are able to convert it every day The number of new cases is reduced by 50%, every 100 days or less with the widespread use of Viracide™ mask.
Dr. Anshu Padayachee, CEO of the South African Technology Network (SATN) said: “Due to the escalation of fungi and susceptible diseases, consumer awareness and health issues have driven the demand for breathable antibacterial/antiviral coatings. In this particular mask The addition of antibacterial/antiviral agents not only improves the reusability of the mask, but also is comfortable and has a pleasant cinnamon scent. In addition, it is a reusable antibacterial mask, the fact that it will definitely reduce demand The surge and supply chain pressure. It has been determined that by providing in-situ real-time antibacterial control, antibacterial/antiviral masks perform better than traditional masks. I strongly recommend children, adults, and health professionals to use this mask."
In addition, Dr. Chandraprakash Naidoo, Medical Director of ARCA Rehabilitation Center in South Africa said: “Arca Durban is a multidisciplinary drug use disorder treatment center located in Durban and Sandton, South Africa. Our plan includes a highly focused medical detox ward and a comprehensive psychosocial Plans. These plans are highly interactive in nature. Therefore, we need an efficient mask that is reasonably priced, reusable, and highly designed, which is important for the agency to protect our patients and patients during the current COVID-19 pandemic and beyond. The simultaneous and effective operation of employees is essential. The Viracide™ mask meets all of the above requirements and is a very welcome addition to our safety protocol."
John Gentile, co-founder of Vitiprints, said: "Vitiprints and its partners are honored that our Viracide™ masks have been accepted in many countries/regions around the world. We believe that our masks can protect everyone with a real anti-viral coating. , This coating can stop COVID-19 and its variants in one minute, and the weekly cost is a few cents per day. We are proud to provide the world with a new tool in the global fight against COVID-19, The cost-effectiveness of this tool makes it valuable in every corner of the world. South Africa became one of the first countries to join the Viracide™ Deactivation Nation global movement because we are focused on our mission, which is to inactivate COVID-19 and others Pathogens, to create a safer and healthier planet for all."
Viracide™ masks are currently available in selected international regions. Due to the overwhelming efficacy of its proprietary coating, the company is in the final stages of completing the US FDA 510K and CE certification testing requirements by December 2021. After obtaining the FDA and CE pre-market certification, Viracide™ masks will be provided to government agencies, medical organizations and consumers in the United States and throughout Europe.
Vitiprints LLC is committed to creating unique anti-viral and anti-bacterial formulas for printing delivery systems to protect industries and families through masks, PPE, filtration, packaging, etc. Vitiprints also applies its advanced printing technology to eliminate water and fillers in vitamins, beverages, milk, pharmaceuticals, personal care and cleaning products by significantly reducing weight, size and cost, thereby uniquely manufacturing food and non-food grade products. Vitiprints' proprietary and patent-pending delivery system technology reduces the need for plastic packaging or components by printing full-featured, cost-effective products, thereby addressing environmental impacts, logistics constraints, and margin pressures. Its customizable printing technology platform utilizes high-speed and efficient equipment to quickly and cost-effectively expand production capacity in many high-volume industries.
Vitiprints/Viracide Joanna Black | 646-912-2681 info@viracidemasks.com info@vitiprints.com Website: www.viracidemasks.com UMS Africa Contact: sales@vafricaglobal.com Website: www.vafricaglobal.com
VITIPRINTS LLC launches VIRACIDE™ masks in Africa, which can invalidate COVID-19 and its variants in one minute
Vitiprints/Viracide Joanna Black | 646-912-2681 info@viracidemasks.com info@vitiprints.com Website: www.viracidemasks.com UMS Africa Contact: sales@vafricaglobal.com Website: www.vafricaglobal.com